News May 27, 2014 Indonesia’s BPOM Grants IND Approval for SCI to Conduct a Phase II Clinical Trial Using Stemedica’s Mesenchymal Stem Cells to Treat Acute Myocardial Infarction SAN DIEGO — May 27, 2014 — Stemedica Cell Technologies Inc., a leading manufacturer of adult, allogeneic
Read More